Abstract
Introduction
Aromatherapy, a form of phytotherapy or botanical medicine, uses essential oils (EOs) as therapeutic agents. EOs have a long history of traditional use, including military hospitals in World Wars I and II. Gattéfosse, a French chemist, is credited with coining the term 'aromatherapy' after he burned his hands in a laboratory explosion. He immediately immersed his hands in a vat of lavender EO, which reduced the pain. His hands subsequently healed without scarring or infection. The aim of this review is to discuss the general safety and quality issues of aromatherapy.
Discussion
The author has referenced some of its own studies in this review. The protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed.
Defi ning Aromatherapy
Aromatherapy is a well-known but misleading term. Several definitions of aromatherapy are in common use including '… the use of odorants as inhalants to treat underlying medical or psychiatric symptoms' 1 . Hirsch's definition is simple, but it does not encompass the range of application/ administration methods used by the aromatherapists. Similarly, it does not differentiate between the EOs and fragrant or synthetic oils (FOs). Aromatherapists do not usually use FOs for therapeutic purposes. In this article, ' Aromatherapy' is used to refer to
The controlled use of essential oils from named botanical sources using a variety of application (external) , which is based on the principles of Quality Use of Medicines (QUM) 3 and encompasses the entire EO pathway from extraction to clinical use. QUM is an appropriate practice framework when EOs are used therapeutically.
• the qualifications and competence of practitioners • prescribing EOs based on an accurate diagnosis following an holistic health assessment • using the botanical name of the plant/s the EO/s was extracted from
• considering the evidence for the purpose the EO was chosen (research data and traditional use) as well as the safety and benefit for the particular individual.
• the administration/application method • appropriately documenting the assessment and EO selection and administration processes, reporting adverse events when relevant, and a plan for monitoring the outcomes according to the aims of the treatment • appropriately storing EOs to reduce deterioration and oxidation and meet infection control and other relevant standards • conforming to relevant product and advertising regulatory requirements and professional standards and codes
The term 'named botanical sources' distinguishes EOs from chemically derived FOs and stresses the importance of using botanical names to distinguish among plant species because EOs from different plants have different chemical compositions, and therefore different actions. In addition, common names differ among localities and countries. EOs derived from different parts of the same plant also have different properties, thus, the part of the plant used could also be encompassed in the definition.
Aromatherapy Practice Models
There are three main aromatherapy practice models that describe how EOs are applied/administered, the doses and dose intervals and safety: medical, subtle and popular. All three models use EOs as the main medicinal substance. EOs are rarely used undiluted; they are incorporated into various carrier substances depending on the application/administration route. EOs are also self-prescribed by the general public, often using self-care books and articles from the Internet that do not contain important safety and other relevant information.
Medical aromatherapy

Phytochemistry and Standards
EOs are extracted from the leaves, flowers, stems, fruit, seeds, bark and roots of a range of aromatic plants EOs are stored in secretory structures in various parts of plants, often with resins and gums in oil cells, sacs, resin canals, ducts and hairs. EOs are extracted using several processes depending on the part of the plant, which are as follows:
Once the EO is extracted, the chemical composition is determined using analytical techniques such as gas chromatography, mass spectrometry, which are frequently considered together, infrared spectroscopy, optical rotation and refractive index. These tests determine whether the EO meets the composition standards. Analytical information is compiled into material safety data sheets (MDSs), which can be obtained from reputable EO suppliers. More recently, researchers have begun to investigate the peroxide value (POV) (an indicator of oxidation) of EOs and fixed vegetable oil carrier oils. POV is an indicator of the possibility an EO could cause skin irritation or sensitivity [8] [9] [10] . More than 3000 phytochemicals have been identified in EOs. Phytochemicals are generally aromatic, derived from the shikimate pathway or terpenoid, derived via the deoxy-xylulose phosphate pathway 11 . 6, 12, 20 . In most cases, aromatherapists use a blend of essential oils depending on the condition being treated. The composition of the blend is modified according to the individual's response to treatment, in much the same way herbal and conventional medicines are prescribed and monitored. Most aromatherapists do not recommend using FOs for therapeutic purposes, although they may have a role in environmental fragrancing and may have psychological effects.
Carrier Substances
In most cases, essential oils are dispersed in a substance known as a carrier. Carrier substances used for massages are usually cold pressed or fixed vegetable oils such as sweet almond, grape seed and macadamia nut oil depending on the aims of treatment. Many fixed vegetable oils such as calendula (Calendula officinalis) and St. John's wort (Hypericum perforatum) also have therapeutic properties in their own right. Other carriers include honey, Aloe vera and specially formulated gel and wax capsules and suppositories to which EOs are added for internal use.
EOs are hydrophobic, thus a dispersant may be required if the EOs are added to water or hydrosols to keep the EOs in solution. Interestingly, hydrophobicity enables EOs to partition with the lipid in bacterial cell membranes and mitochondria, which changes these structures and makes them more permeable 5 . If essential molecules and ions leak from the bacteria they die. Research is currently being undertaken to determine the antibacterial properties of a range of EOs. Several studies suggest that they are more effective against gram-negative organisms [21] [22] [23] . Hydrosols are a by-product of EO steam distillation and contains between 0.05 and 0.02 ml of EO oil per litre. Hydrosols are used as carrier substances, prepared as tinctures, spritzers, compresses, and ingested as tonics 24 . EOs have a range of actions including antioxidant, antiinflammatory, antibacterial, antiviral, sedative, stimulant, analgesic, antitussive and immune-modifying 23, [25] [26] [27] [28] .
Clinical Uses
Despite the wealth of information about what EOs are 'good for,' there is a limited amount of rigorous clinical research to support many of the claims largely due to methodological issues such as short duration, small sample sizes, invalid tools and lack of rigor relevant to the method 27, 29 . Most research into the pharmacodynamics and pharmacokinetics of EO is undertaken in animal studies often using single isolated phytochemicals or in petri dishes in the laboratory. A few studies have compared phytochemicals with conventional medicines.
Research indicates that EOs are metabolised and excreted 72-120 h after they are applied/administered depending on the • size of the animal; however, animal studies may not directly apply to humans; although they provide important pharmacological information about EOs that is useful for determining areas for future research and can aid clinical decisions.
• chemical composition of the EO • application/administration method • dose and dose interval and duration of treatment. Some EOs have a cumulative effect.
• individuals' state of health EOs are absorbed through the skin but the absorption rate of different EOs and the phytochemical composition of a particular EO varies, depending on a number of factors including the size of the individual phytochemicals. Jager et al. 30 detected linalool and linayl acetate (components of lavender) in blood 5 min after a 10-min abdominal massage using 2% Lavandula angustifolia in peanut oil. Similarly, salicylate can be detected in subcutaneous tissue within 30 min for up to 60 min after applying 20% methyl salicylate to the forearm 31 . Bigger molecules such as the coumarins take up to an hour to penetrate 32 .
Research suggests some EOs can enhance the absorption of topically applied medicines. Chemical components such as limonene, 1,8-cineole and nerolidol enhance the penetration of both hydrophilic and lipophilic substances [33] [34] [35] . Such research suggests that topical application of EOs might be contraindicated or that caution might be required if topical conventional medicines, such as anti-anginal agents, nicotine patches and hormones, are used at the same time. Alternatively, enhancing medicine absorption could be beneficial if a fast onset of action is needed.
EOs are absorbed, metabolised and excreted in a similar way to fatsoluble medicines 25 . EOs have a short lifespan in the blood from where they are distributed to muscle and adipose tissues over a longer period. EOs may bind to plasma proteins for transportation and are largely detoxified in the liver. The exact pharmacokinetics and pharmacodynamics depend on the route of administration and the chemical composition of the EO or EO blend.
Safety
EO safety is complex. Safety data are largely based on the long history of safe traditional use, case reports and animal studies 36 . EO safety information can be found in MDSs,
Competi ng interests: none declared. Confl ict of Interests: none declared.
All authors contributed to the concepti on, design, and preparati on of the manuscript, as well as read and approved the fi nal manuscript.
All authors abide by the Associati on for Medical Ethics (AME) ethical rules of disclosure.
Licensee German Commission E Monographs and ESCOP Monographs as well as from Poisons Information Centres. As indicated, composition standards are an important aspect of safety and EO risk profile. Health professionals and the general public are advised to buy essential oils from reputable sources that label and store them appropriately for safety and medicolegal reasons. Aromatherapists and the public should be educated to read EO labels, which should contain information about • botanical name, species, and if relevant the chemotype of the plant from which the oil was extracted or in the case of a blend, for all the EOs in the blend
• the part or parts of the plant from which the essential oil was extracted • the names of any dispersants, incipients and preservatives • the country where the plants were grown (country of origin) • extraction method • a statement of purity. However, this is not a regulatory requirement and not all suppliers make such statements.
• batch number so that the batch can be identified if an adverse event occurs to determine whether the reaction was idiosyncratic or occurred because of the manufacturing process • expiry date • manufacture's details
The most common adverse events are eye, mucous membrane and skin irritation and sensitisation particularly to oils containing aldehydes and phenols, and phototoxicity to EOs that contain furocoumarins, for example Citrus bergamia. Contact sensitisation is more likely to occur due to oxidation of monoterpenes, often due to inappropriate storage conditions 25, 37 . Cross-sensitisation to other EOs and foods is also possible. Allergy from inhaled essential oils can occur; however, data about exposure levels are limited and many of the reports concern perfumes rather than aromatherapy EOs
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. Cumulative effects can occur with prolonged use. EOs that are not commonly used in aromatherapy are associated with Inhibits monoamine oxidase inhibitor acti on β-Asarone and d-pulegone Potenti ate the toxic eff ect of medicines by depleti ng liver P 450 enzyme system Eugenol, menthol, oil of wintergreen and possibly white birch especially if repeated applicati ons are used during the day.
Increases anti coagulant acti vity of anti coagulants and aspirin, therefore, increases bleeding risk. When applied in massage the force of the massage rather than the essenti al oils may represent a risk of bruising and bleeding. Valerian Central nervous system depressant prolongs eff ects and increases the risk of prolonged sleep, drowsiness and falls. Primrose oil Interacts with promethazines, for example chlorpromazine is used to manage schizophrenia and can induce seizures.
Interactions between topically applied essential oils and medicines are unlikely except when they are both applied to the same local site 20, 39 .
Licensee cancer, neurotoxicity (ketones) and hepatoxicity in large doses in animals and are most likely to occur with internal use 25 .
Essential oil-Medicine Interactions
It is difficult to determine the interaction between conventional herbal medicine and essential oil 38 . Only very small amounts of EOs are absorbed from topical applications, which makes interactions unlikely; however, topical application of both the EO and the medicine to the same area may enhance the absorption of medicine. The potential for interactions increases with internal use (see Table 1 ). Some tips to improve safe use of EOs are shown in Table 2 .
Conclusion
Essential oils can be a useful nonmedicinal option or combined with conventional care for some health conditions, provided safety and quality issues are considered. People with a history of allergies and eczema can develop sensiti vity to any EOs.
EOs containing aldehydes and phenols are more likely to cause allergic reacti ons. Patch testi ng before using EOs for the fi rst ti me may be indicated especially in at-risk individuals.
The risk of serious adverse events is higher when EOs are administered internally.
Using the same EO or EO blend oils for long periods may lead to cumulati ve eff ects and cause sensiti vity over ti me.
Although quality evidence to support traditi onal EO use is lacking, traditi onal precauti ons and contraindicati ons concerning pregnancy and lactati on, epilepsy, asthma people with alcohol or addicti ons and doses in certain age groups and disease states should be considered.
Use recommended traditi onal EO doses and dose intervals. Most aromatherapists use low doses, although eff ecti ve therapeuti c doses and dose ranges for specifi c EOs and clinical indicati ons are unclear.
Some EOs oils are not used in aromatherapy for example wormwood, pennyroyal, rue, camphor, bitt er almond and sassafras because of their known toxicity. Oil of wintergreen is someti mes included on aromatherapy EO exclusion list; however, if it is used appropriately, it is an eff ecti ve analgesic in a massage blend for muscular aches and arthriti c pain.
EOs must be appropriately stored to prevent oxidati on and degradati on and preserve their therapeuti c eff ects and kept out of the reach of children and cogniti vely impaired or suicidal pati ents to avoid inadvertent or deliberate overdose. Vaporisers should also be placed out of reach.
EOs are highly fl ammable. Products must be used and disposed of appropriately to reduce the fi re risk.
Educati ng people who self-administer/apply EOs is an important aspect of safe use. Educati on includes consulti ng appropriately qualifi ed, reputable aromatherapists and the importance of reading EO labels.
